Global Point-of-Care Diagnostics Market to Reach $114.65 Billion by 2035

The healthcare diagnostics industry is undergoing a seismic shift, with point-of-care (POC) testing moving from niche use cases to mainstream clinical practice. A new report from market research firm SNS Insider confirms this momentum, projecting the global point-of-care diagnostics market will hit a valuation of USD 114.65 billion by 2035.

This growth reflects a broader push toward decentralized, patient-centric healthcare, where rapid test results enable faster treatment decisions and better health outcomes for patients worldwide.

What Are Point-of-Care Diagnostics?

For those new to the space, point-of-care diagnostics (POC) refer to medical tests performed at or near the location of patient care, rather than in a centralized laboratory. These tools deliver results within minutes, eliminating the wait times associated with traditional lab testing.

Common examples include rapid COVID-19 tests, glucose monitors for diabetes management, and handheld blood analyzers used in emergency rooms and rural clinics.

Key Drivers Fueling Market Growth

Several converging factors are driving the expansion of the global point-of-care diagnostics market, per the SNS Insider analysis:

• Rising chronic disease burden: The growing prevalence of diabetes, cardiovascular disease, and infectious diseases is increasing demand for frequent, accessible monitoring tools.
• Decentralized healthcare demand: Rural and resource-limited regions with limited access to centralized labs are adopting POC tools to expand diagnostic access.
• Technological innovation: Advances in miniaturization, AI integration, and wireless connectivity are making POC devices more accurate, affordable, and user-friendly.
• Post-pandemic consumer habits: The COVID-19 pandemic normalized at-home testing, with patients increasingly preferring convenient, self-administered diagnostic kits.
• Supportive policy: Governments in emerging economies are rolling out initiatives to expand affordable diagnostic access, boosting POC adoption.

Regional Market Outlook

North America currently holds the largest share of the point-of-care diagnostics market, thanks to advanced healthcare infrastructure, high R&D investment, and early adoption of novel diagnostic technologies. The U.S. accounts for the majority of regional revenue, driven by strong demand for home-based testing and rapid emergency care tools.

However, the Asia-Pacific region is poised to register the fastest CAGR through 2035. Expanding healthcare access, rising disposable income, and growing awareness of early disease detection in markets like India, China, and Southeast Asia are key growth drivers for the region.

Emerging Trends Shaping the Market

AI and IoT Integration

Modern POC devices are increasingly embedding artificial intelligence (AI) and Internet of Things (IoT) capabilities. These features allow real-time data sharing with healthcare providers, automated result analysis, and remote patient monitoring, reducing administrative burden on clinical teams.

Expansion of Home-Based Testing

Home-based POC kits are no longer limited to glucose monitoring or pregnancy tests. Newer offerings include rapid tests for infectious diseases, cholesterol screening, and even wearable diagnostic devices that track health metrics continuously. This trend is driving sustained demand from both consumers and healthcare systems.

Challenges to Market Adoption

Despite strong growth prospects, the point-of-care diagnostics market faces several barriers:

• Stringent regulatory approvals for new diagnostic devices, which can delay time-to-market
• High upfront costs for advanced POC systems, limiting adoption in low-resource settings
• Perceived accuracy gaps compared to centralized laboratory testing, though technology is closing this divide

Conclusion

The SNS Insider report highlights the transformative potential of the point-of-care diagnostics market over the next decade. As healthcare systems prioritize speed, accessibility, and patient convenience, POC testing will become a cornerstone of global diagnostic strategies.

Stakeholders across the value chain – from device manufacturers to healthcare providers and policymakers – must collaborate to address regulatory and cost barriers, ensuring the benefits of POC diagnostics reach patients worldwide.